MDS Proteomics Reports Third Quarter 2002 Earnings; Hopes for Partner by Year’s End

In MDS’ third quarter 2002 fiscal year earnings report, released September 19, MDS Proteomics’ revenue and burn rate remained unchanged from the comparable period a year ago. In both periods, MDSP earned $1 million Canadian ($630,000) in revenue, and spent $12 million Canadian ($7.6 million). The impact on MDS’ earnings due MDSP’s cash burn increased from six cents a share from 5 cents a share a year ago.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.